The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and ...

Seeking Behaviors for Acute Asthma: A US Cross-sectional Survey,” published in the April 2025 issue of Annals of Allergy, Asthma & Immunology by Gardner et al. Understanding why patients seek acute ...

Patients with severe asthma initiated dupilumab and tezepelumab treatment more often than other biologics between 2022 and ...

A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to chronic rhinosinusitis.

Among patients with mild-persistent asthma with high SABA use, increased adherence to ICS decreased the proportion of patients with at least 1 exacerbation. Patients with mild asthma have a high level ...

The most common causes of chronic cough include gastroesophageal reflux disease (GERD), asthma, and postnasal drip (also ...

Patients with severe asthma required fewer steroid bursts with tezepelumab-ekko, according to a poster presented at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization ...

Medically reviewed by Sanja Jelic, MD Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory (lung) ...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...

The following is a summary of “Plasma pharmacometabolomics of inhaled corticosteroid-related adrenal suppression in asthma,” published in the March 2025 issue of Journal of Allergy and Clinical ...

When he was 10, she noticed he was wheezing. She took him to a hospital and learned he had asthma, a chronic condition that ...